Quick Answer
Encompass Health Corp reported Cash and Equivalents of $72.20 million for fiscal year 2025.
Encompass Health Corp Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $72.20M | -15.5% |
| 2024 | $85.40M | +23.6% |
| 2023 | $69.10M | +217.0% |
| 2022 | $21.80M | -55.9% |
| 2021 | $49.40M | -73.4% |
| 2020 | $185.60M | +209.3% |
| 2019 | $60.00M | -13.3% |
| 2018 | $69.20M | +27.2% |
| 2017 | $54.40M | +34.3% |
| 2016 | $40.50M | -34.3% |
| 2015 | $61.60M | -7.6% |
| 2014 | $66.70M | +3.4% |
| 2013 | $64.50M | -51.4% |
| 2012 | $132.80M | +341.2% |
| 2011 | $30.10M | -37.7% |
| 2010 | $48.30M | -40.1% |
| 2009 | $80.70M | +154.6% |
| 2008 | $31.70M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $48.70M | -67.1% | -50.9% |
| June 30, 2025 | $99.10M | -35.8% | +3.4% |
| March 31, 2025 | $95.80M | -28.7% | +12.2% |
| December 31, 2024 | $85.40M | +23.6% | -42.2% |
| September 30, 2024 | $147.80M | +48.2% | -4.3% |
| June 30, 2024 | $154.40M | +31.4% | +14.9% |
| March 31, 2024 | $134.40M | +58.1% | +94.5% |
| December 31, 2023 | $69.10M | +217.0% | -30.7% |
- Encompass Health Corp showed a decrease of -15.5% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2025 period, Encompass Health Corp’s cash and equivalents has grown by 127.8% (from $31.70 million to $72.20 million).
- The most recent figure is from Encompass Health Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: